Featured Investment Ideas
- PropThink’s Weekly Biotech Round-Up
By Editorial Staff · Fri, May 17
Cell therapy developers Athersys and Cytomedix target the immense stroke treatment market. Mr. Napodano laid out the theses for these two stem cell developers, although he’s more bullish on CMXI for the time being. News this week that Trius had patented a tidezolid/daptomycin combination has an · more »
- Value Investors Take Note: Fire Sale on this Heart Failure Asset
By Jake King · Fri, May 17 - Trius Patent Intrigues Investors, And Perhaps Cubist Pharmaceuticals
By Jason Napodano, CFA · Thu, May 16 - Markman Hearing A Likely Clearing Event For Cubist: Decision Any Day
By Jake King · Tue, May 14
Latest News
- Revisiting Synergy Ahead of An Event-Driven Week: Plecanatide Data is Forthcoming
By Jake King · Fri, May 17 - An FDA Meeting Becomes New Focus for Titan Pharma
By Jason Napodano, CFA · Fri, May 17 - Ahead of Incremental Catalysts, Immunomedics’ Options are Compellingly Priced
By Ivan Deryugin · Wed, May 15 - MAKO Surgical: Burden of Proof Still on Management
By Jake King · Thu, May 9
- Previewing MAKO Surgical’s First Quarter: A Pivotal Earnings Release
By Ivan Deryugin · Mon, May 6 - The ODAC Postmortem: Lessons Learned Part 2, Delcath Systems
By Aafia Chaudhry, MD · Mon, May 6 - Picking Up What’s Left of Aveo
By Jake King · Fri, May 3 - The ODAC Postmortem: Lessons Learned Part 1, AVEO
By Aafia Chaudhry, MD · Fri, May 3
Most Popular
- PropThink’s Weekly Biotech Round-Up
By Editorial Staff · Fri, May 17 - Revisiting Synergy Ahead of An Event-Driven Week: Plecanatide Data is Forthcoming
By Jake King · Fri, May 17 - An FDA Meeting Becomes New Focus for Titan Pharma
By Jason Napodano, CFA · Fri, May 17 - Value Investors Take Note: Fire Sale on this Heart Failure Asset
By Jake King · Fri, May 17
- Trius Patent Intrigues Investors, And Perhaps Cubist Pharmaceuticals
By Jason Napodano, CFA · Thu, May 16 - Ahead of Incremental Catalysts, Immunomedics’ Options are Compellingly Priced
By Ivan Deryugin · Wed, May 15 - Markman Hearing A Likely Clearing Event For Cubist: Decision Any Day
By Jake King · Tue, May 14 - Does Cell Therapy Hold The Key To Treating Stroke?
By Jason Napodano, CFA · Mon, May 13
